Figure 2.
P3–P1′ spanning HCV NS3/4A protease inhibitor (1), its P3 truncated analogue (2), and a proline-based HCV NS3/4A protease inhibitor (3).14
P3–P1′ spanning HCV NS3/4A protease inhibitor (1), its P3 truncated analogue (2), and a proline-based HCV NS3/4A protease inhibitor (3).14